
Conatus Pharma (CNAT)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Conatus Pharma (CNAT) Stock
Start investing in Conatus Pharma (CNAT)
About Conatus Pharma (CNAT)
Market cap | $1.3K |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 489.21 |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | — |
Today's range | — |
Debt / equity | — |
52 week range | $0 - $0.3 |
5 year debt / equity | — |
Beta (LTM) | — |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | May 1, 2020 |
Dividend payable date | — |
Conatus Pharma Stock News
View all



Frequently Asked Questions (FAQ)
How to buy CNAT stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in CNAT stock
Navigate to the Explore page. Then, type CNAT into the search bar. When you see CNAT stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased CNAT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Conatus Pharma Stock Earnings
The value each CNAT share was expected to gain vs. the value that each CNAT share actually gained.
Conatus Pharma (CNAT) reported earnings per share (EPS) of $0, — estimates of $0 by —. In the same quarter last year, Conatus Pharma's earnings per share (EPS) was $0. Conatus Pharma is expected to release next earnings on 05/01/2020, with an earnings per share (EPS) estimate of $0.